TF Capital
Finance · China · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Unit801 Cpic Xintiandi Tower 2 288 Xizan...Website
www.tfcapital.netRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About TF Capital
TF Capital is a leading investor focused on partnering with early-stage innovators in the biotech sector. They provide comprehensive capital and strategic expertise, supporting promising biotech companies globally. With over $1 billion in assets under management and a diverse portfolio of more than 100 companies, TF Capital has successfully facilitated numerous IPOs and licensing deals. Their strategic expansion into key biopharma hubs aims to foster innovation and strengthen collaboration across regions.Explore more
Popular SearchesTF CapitalSIC Code 67,679NAICS Code 52,523Show moreTF Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TF Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once TF Capital has new funding data
TF Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on TF Capital recently announced quarterly report
Click to see if TF Capital had a recent Job posting/layoffs
Product Launch: Get notified when TF Capital launches new products
Congratulate Masked Content for being promoted to Masked Content at TF Capital
Check out if TF Capital is spiking on competitors!
Check if TF Capital has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined TF Capital as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
TF Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
TF Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about TF Capital.
TF Capital Tech Stack
A closer look at the technologies used by TF Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
TF Capital News & Media
AskGene Limited Announces Completion of USD 20 Million Series A Financing Led by Qiming Venture Partners and TF Capital
CAMARILLO, Calif. and NANJING, China, May 8, 2022 /PRNewswire/ -- AskGene Limited ("AskGene"), a clinical-stage biopharmaceutical company focusing on discovery and development of innovative biological drugs, today announced the completion of USD 20 million in Series A financing. The...Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
Venture capital news. Updated daily. VC deal news, fund news, transition news, industry news.Cytovia Therapeutics and its Newly Formed China-Focused CytoLynx Joint Venture Raise $45 Million to Advance NK Cell Therapy Pipeline
AVENTURA, Fla. and SHANGHAI, China, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc. (“Cytovia”), a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited iNK and CAR (Chimeric Antigen Receptor)-iNK cells derived from induced pluripotent stem cells (iPSCs) and NK cell engager multifunctional antibodies, and CytoLynx Therapeutics (“CytoLynx), its newly-formed China-focused joint venture, announced today that they have closed $45 million from institutional investoRegor Therapeutics Announces Completion of $90 Million Series B Financing
SHANGHAI, Feb. 18, 2021 /PRNewswire/ -- Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing. Founded in...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TF Capital
Sign Up For FreeTo access detailed company insights
TF Capital is a leading investor focused on partnering with early-stage innovators in the biotech sector. They provide comprehensive capital and strategic expertise, supporting promising biotech companies globally. With over $1 billion in assets under management and a diverse portfolio of more than 100 companies, TF Capital has successfully facilit... Read More
